デフォルト表紙
市場調査レポート
商品コード
1701884

無細胞タンパク質発現(CFPE)市場:製品別、方法別、用途別、エンドユーザー別、地域別、2025-2033年

Cell-free Protein Expression Market Report by Product, Method, Application, End User, and Region 2025-2033


出版日
発行
IMARC
ページ情報
英文 148 Pages
納期
2~3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
無細胞タンパク質発現(CFPE)市場:製品別、方法別、用途別、エンドユーザー別、地域別、2025-2033年
出版日: 2025年04月01日
発行: IMARC
ページ情報: 英文 148 Pages
納期: 2~3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

無細胞タンパク質発現(CFPE)市場の世界市場規模は2024年に2億8,350万米ドルに達しました。今後、IMARC Groupは、市場は2033年までに5億1,510万米ドルに達し、2025年から2033年にかけて6.52%の成長率(CAGR)を示すと予測しています。同市場は、主に個別化医療、ワクチン開発、合成生物学の進歩によって大きな成長を遂げています。医薬品とバイオテクノロジーにおけるコスト効率と柔軟性に優れたソリューションに対する需要の高まりは、市場の成長をさらに後押しし、CFPEを重要な業界イネーブラーとして位置づけています。

無細胞タンパク質発現(CFPE)とは、細胞から抽出した生体分子翻訳装置を用いて、溶液中で目的の組換えタンパク質を生産することを指します。CFPEは、大腸菌、ウサギ網状赤血球、小麦胚芽、昆虫細胞、哺乳類無細胞タンパク質発現(CFPE)系など、さまざまな細胞溶解物を用いて実施することができます。CFPEは、酵素工学、タンパク質標識、タンパク質精製、タンパク質間相互作用、変異体のハイスループット生産などに広く用いられています。CFPEはまた、タンパク質の安定性、分解、フォールディングに必要な成分の分析にも用いられます。細胞ベースのタンパク質発現と比較すると、無細胞タンパク質発現(CFPE)は時間効率が高く便利であり、非天然アミノ酸を組み込むことができ、安定性と特異性が向上します。

無細胞タンパク質発現(CFPE)市場動向:

生物科学の急速な進歩は、市場成長を促進する重要な要因の一つです。無細胞タンパク質発現(CFPE)は、遺伝暗号の拡張、ウイルスの組み立て、様々な生体分子プロセスのための組換えタンパク質の合成に広く使用されています。さらに、がんや感染症の治療のための抗体、抗菌薬、サイトカインなどのタンパク質ベースの治療薬を開発するための製薬業界における技術利用の増加は、別の成長促進要因として作用しています。さらに、効率的なプロトタイピングとハイスループット実験のためにシステムを最適化することで、タンパク質生産収率を向上させる機械学習(ML)アルゴリズムの統合が、市場成長の原動力となっています。さらに、連続交換無細胞(CECF)タンパク質合成システムを使用して複雑な原核生物および真核生物タンパク質を生産するための新規プロセスの導入は、市場に明るい見通しを生み出しています。その他の要因としては、バイオ製造やプロトタイピングにおける無細胞法の広範な採用、プロテオミクスやゲノミクスにおける広範な研究開発(R&D)活動、病原体感知、炎症反応、個別化医療などの診断用途におけるヘルスケア業界での採用の高まりなどがあり、市場の成長を後押ししています。

本レポートで扱う主な質問

  • 2024年の世界の無細胞タンパク質発現(CFPE)市場の市場規模は?
  • 2025-2033年の世界の無細胞タンパク質発現(CFPE)市場の予想成長率は?
  • 世界の無細胞タンパク質発現(CFPE)市場を牽引する主要因は何か?
  • 世界の無細胞タンパク質発現(CFPE)市場に対するCOVID-19の影響は?
  • 世界の無細胞タンパク質発現(CFPE)市場の製品別内訳は?
  • 世界の無細胞タンパク質発現(CFPE)市場の方法別の内訳は?
  • 世界な無細胞タンパク質発現(CFPE)市場の用途別の内訳は?
  • 世界の無細胞タンパク質発現(CFPE)市場のエンドユーザー別内訳は?
  • 無細胞タンパク質発現(CFPE)市場の世界における主要地域は?
  • 世界の無細胞タンパク質発現(CFPE)市場における主要プレイヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の無細胞タンパク質発現(CFPE)市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:製品別

  • 発現系
    • 主要セグメント
      • 大腸菌
      • 小麦胚芽
      • ウサギ網状赤血球
      • 昆虫細胞
      • ヒト
      • その他
  • 試薬

第7章 市場内訳:方法別

  • 転写・翻訳系
  • 翻訳系

第8章 市場内訳:用途別

  • 酵素工学
  • 高スループット生産
  • タンパク質標識
  • タンパク質間相互作用
  • タンパク質精製

第9章 市場内訳:エンドユーザー別

  • 製薬・バイオテクノロジー企業
  • 学術研究機関
  • その他

第10章 市場内訳:地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場内訳:国別

第11章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Bioneer Corporation
    • biotechrabbit GmbH
    • Cambridge Isotope Laboratories Inc.(Otsuka Pharmaceutical Co. Ltd.)
    • CellFree Sciences Co. Ltd.
    • Cube Biotech GmbH
    • GeneCopoeia Inc.
    • Jena Bioscience GmbH
    • Merck KGaA
    • New England Biolabs
    • Promega Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Cell-free Protein Expression Market: Major Drivers and Challenges
  • Figure 2: Global: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Cell-free Protein Expression Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Cell-free Protein Expression Market: Breakup by Method (in %), 2024
  • Figure 6: Global: Cell-free Protein Expression Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Cell-free Protein Expression Market: Breakup by End User (in %), 2024
  • Figure 8: Global: Cell-free Protein Expression Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Cell-free Protein Expression (Expression Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Cell-free Protein Expression (Expression Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Cell-free Protein Expression (Reagents) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Cell-free Protein Expression (Reagents) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Cell-free Protein Expression (Transcription and Translation Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Cell-free Protein Expression (Transcription and Translation Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Cell-free Protein Expression (Translation Systems) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Cell-free Protein Expression (Translation Systems) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Cell-free Protein Expression (Enzyme Engineering) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Cell-free Protein Expression (Enzyme Engineering) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Cell-free Protein Expression (High Throughput Production) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Cell-free Protein Expression (High Throughput Production) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Cell-free Protein Expression (Protein Labeling) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Cell-free Protein Expression (Protein Labeling) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Cell-free Protein Expression (Protein-Protein Interaction) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Cell-free Protein Expression (Protein-Protein Interaction) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Cell-free Protein Expression (Protein Purification) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Cell-free Protein Expression (Protein Purification) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Cell-free Protein Expression (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Cell-free Protein Expression (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Cell-free Protein Expression (Academic and Research Institutes) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Cell-free Protein Expression (Academic and Research Institutes) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Cell-free Protein Expression (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Cell-free Protein Expression (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: North America: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: North America: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: United States: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: United States: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Canada: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Canada: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Asia-Pacific: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Asia-Pacific: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: China: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: China: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Japan: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Japan: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: India: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: India: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: South Korea: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: South Korea: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Australia: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Australia: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Indonesia: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Indonesia: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Others: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Others: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Europe: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Europe: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: Germany: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: Germany: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: France: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: France: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: United Kingdom: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: United Kingdom: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Italy: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Italy: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Spain: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Spain: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Russia: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Russia: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Others: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Others: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Latin America: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Latin America: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Brazil: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Brazil: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Mexico: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Mexico: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Others: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Others: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Middle East and Africa: Cell-free Protein Expression Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Middle East and Africa: Cell-free Protein Expression Market: Breakup by Country (in %), 2024
  • Figure 81: Middle East and Africa: Cell-free Protein Expression Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 82: Global: Cell-free Protein Expression Industry: SWOT Analysis
  • Figure 83: Global: Cell-free Protein Expression Industry: Value Chain Analysis
  • Figure 84: Global: Cell-free Protein Expression Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Cell-free Protein Expression Market: Key Industry Highlights, 2024 & 2033
  • Table 2: Global: Cell-free Protein Expression Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Cell-free Protein Expression Market Forecast: Breakup by Method (in Million USD), 2025-2033
  • Table 4: Global: Cell-free Protein Expression Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Cell-free Protein Expression Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 6: Global: Cell-free Protein Expression Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Cell-free Protein Expression Market: Competitive Structure
  • Table 8: Global: Cell-free Protein Expression Market: Key Players
目次
Product Code: SR112025A6288

The global cell-free protein expression market size reached USD 283.5 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 515.1 Million by 2033, exhibiting a growth rate (CAGR) of 6.52% during 2025-2033. The market is experiencing significant growth mainly driven by advancements in personalized medicine, vaccine development, and synthetic biology. The rising demand for cost-effective, flexible solutions in pharmaceuticals and biotechnology further propels market growth, positioning CFPE as a key industry enabler.

Cell-free protein expression (CFPE) refers to the production of desired recombinant proteins in solution using biomolecular translation machinery extracted from cells. It can be carried out using different cell lysates, such as E. coli, rabbit reticulocytes, wheat germ, insect cells, and mammalian cell-free protein expression systems. They are widely used in enzyme engineering, protein labeling, protein purification, protein-protein interaction, and high throughput production of mutants. CFPE is also used for analyzing components needed for protein stability, degradation, and folding. As compared to cell-based protein expression, cell-free protein expression is time efficient and convenient, allows the incorporation of non-natural amino acids, and provides enhanced stability and specificity.

Cell-free Protein Expression Market Trends:

The rapid advancement in biological sciences is one of the key factors driving the market growth. Cell-free protein expression is extensively used in the expansion of genetic code, assembly of viruses, and the synthesis of recombinant proteins for various biomolecular processes. Furthermore, the increasing technique utilization in the pharmaceutical industry for developing protein-based therapeutics, such as antibodies, antimicrobials, and cytokines, for treating cancer and infectious diseases is acting as another growth-inducing factor. Additionally, the integration of machine learning (ML) algorithms to improve protein production yield by optimizing the system for efficient prototyping and high-throughput experimentation is providing an impetus to market growth. Moreover, the introduction of novel processes to produce complex prokaryotic and eukaryotic proteins using a continuous-exchange cell-free (CECF) protein synthesis system is creating a positive outlook for the market. Other factors, including the widespread adoption of cell-free methods for biomanufacturing and prototyping, extensive research and development (R&D) activities in proteomics and genomics, and the rising adoption in the healthcare industry for diagnostic applications, such as pathogen sensing, inflammatory response, and personalized medicine, are supporting drive the market growth.

Key Market Segmentation:

Breakup by Product:

  • Expression Systems
  • E. coli Cell-free Protein Expression System
  • Wheat Germ Cell-free Protein Expression System
  • Rabbit Reticulocytes Cell-free Protein Expression System
  • Insect Cells Cell-free Protein Expression System
  • Human Cell-free Protein Expression System
  • Others
  • Reagents

Breakup by Method:

  • Transcription and Translation Systems
  • Translation Systems

Breakup by Application:

  • Enzyme Engineering
  • High Throughput Production
  • Protein Labeling
  • Protein-Protein Interaction
  • Protein Purification

Breakup by End User:

  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Bioneer Corporation, biotechrabbit GmbH, Cambridge Isotope Laboratories Inc. (Otsuka Pharmaceutical Co. Ltd.), CellFree Sciences Co. Ltd., Cube Biotech GmbH, GeneCopoeia Inc., Jena Bioscience GmbH, Merck KGaA, New England Biolabs, Promega Corporation, Takara Bio Inc. and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global cell-free protein expression market in 2024?
  • 2.What is the expected growth rate of the global cell-free protein expression market during 2025-2033?
  • 3.What are the key factors driving the global cell-free protein expression market?
  • 4.What has been the impact of COVID-19 on the global cell-free protein expression market?
  • 5.What is the breakup of the global cell-free protein expression market based on the product?
  • 6.What is the breakup of the global cell-free protein expression market based on the method?
  • 7.What is the breakup of the global cell-free protein expression market based on application?
  • 8.What is the breakup of the global cell-free protein expression market based on the end user?
  • 9.What are the key regions in the global cell-free protein expression market?
  • 10.Who are the key players/companies in the global cell-free protein expression market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cell-free Protein Expression Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Expression Systems
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 E. coli Cell-free Protein Expression System
      • 6.1.2.2 Wheat Germ Cell-free Protein Expression System
      • 6.1.2.3 Rabbit Reticulocytes Cell-free Protein Expression System
      • 6.1.2.4 Insect Cells Cell-free Protein Expression System
      • 6.1.2.5 Human Cell-free Protein Expression System
      • 6.1.2.6 Others
    • 6.1.3 Market Forecast
  • 6.2 Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Method

  • 7.1 Transcription and Translation Systems
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Translation Systems
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Enzyme Engineering
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 High Throughput Production
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Protein Labeling
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Protein-Protein Interaction
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Protein Purification
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Pharmaceutical and Biotechnology Companies
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Academic and Research Institutes
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bioneer Corporation
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
    • 15.3.2 biotechrabbit GmbH
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Cambridge Isotope Laboratories Inc. (Otsuka Pharmaceutical Co. Ltd.)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 CellFree Sciences Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Cube Biotech GmbH
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 GeneCopoeia Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Jena Bioscience GmbH
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Merck KGaA
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 New England Biolabs
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Promega Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Takara Bio Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis